|
1 International Agency for Research on Cancer. Cervical cancer screening. IARC handbooks of cancer prevention, vol 10. Lyon: IARC/WHO, 2005, 302.
|
|
2 Tsai CH, Yang CC, Chou LS, et al. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma. J Oral Pathol Med, 2001, 30(9)：527–531.
|
|
3 Ueki T, Hsing AW, Gao YT, et al. Alterations of p16 and prognosis in biliary tract cancers from a population–based study in China. Clin Cancer Res, 2004, 10(5): 1717–1725.
|
|
4 Xin H, Geng M, Chen SF, et al. Evaluation of expressions and clinical significance of p16～(INK4a) and PCNA in uterine cervix carcinoma and cervical intraepithelial neoplasia. Chin J Cancer Prev Treat, 2007, 10(20): 1563–1567.[辛海，耿明，陈诵芬，等．宫颈癌及其癌前病变组织中p16INK4a和PCNA的表达及临床意义．中华肿瘤防治杂志，2007, 10(20): 1563–1567.]
|
|
5 Liu P, Liu YL. Prospective cohort research on cervical carcinoma screening of thinprep cytological test combined with human papilloma virus hybrid capture. Chin J Obstet Gynecol Pediatr (Electron Ed), 2009, 5(1): 18–22.[刘萍，刘岩丽．液基薄层宫颈刷片细胞学检查结合二代杂交捕获法人乳头瘤病毒筛查宫颈癌的前瞻性队列研究(J/CD). 中华妇幼临床医学杂志：电子版，2009, 5(1): 18–22.]
|
|
6 Klaes R, Benner A, Friedrich T, et al. p16 INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol, 2002, 26(11): 1389–1399.
|
|
7 Keating JT, Cviko A, Riethdorf S, et al. Ki–67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus–related cervical neoplasia. Am J Surg Pathol, 2001, 25(7): 884–891.
|
|
8 Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol, 2003, 56(1): 56–63.
|
|
9 Fregonesi PA, Teresa DB, Duarte RA, et al. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem, 2003, 51(10): 1291–1297.
|
|
10 Lang JC, Borchers J, Danahey D, et al. Mutational status of overexpressed p16 in head and neck cancer: Evidence for germLine mutation of p16/p14ARF. Int J Oncol, 2002, 21(2): 401–408.
|
|
11 Lin ZH, Shen XH, Jin Z, et al. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. Pathol Int, 2005, 55(8): 491–496.
|
|
12 Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: Segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer, 1995, 61(1): 13–22.
|